Pulmonary nodule
Conditions
Interventions
Control group:Clinical observation
Sponsors
The First Affiliated Hospital of Naval Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria within 21 days prior to screening observation will be included in the study: (1) Gender not limited age between 18-80 years old; (2) The first discovery of pulmonary nodules within 3 months can provide chest CT examination results indicating: 5mm < pure ground glass nodules = 10mm; Single or multiple if multiple with no more than 10 pulmonary nodules and evaluated based on the largest nodule; (3) The nodules have remained stable without growth or dissipation within the past three months; (4) Voluntarily participate in the experiment and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Patients who meet one of the following criteria within 21 days prior to screening and observation will be excluded from the study: (1) Patients with other primary malignant tumors; (2) Diagnosed with pulmonary tuberculosis pulmonary fungal disease pneumonia or other lung diseases with clear causes currently may require Those who need to undergo immediate anti tuberculosis anti fungal anti infection or other related treatments; (3) Lung CT can directly observe malignant signs such as spicules lobulation vascular bundle shadows vacuoles pleural traction and increased solid components in non solid nodules; (4) Diagnosis of spleen kidney yang deficiency based on traditional Chinese medicine syndromes; (5) Individuals with serious illnesses or functional disorders of the heart liver kidneys etc; (6) Pregnant or lactating women; (7) Individuals with mental or cognitive impairments; (8) Participants in other drug trials; (9) Individuals who are allergic to the drugs used in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total efficiency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in tumor markers compared to baseline;Risk score determination for malignant transformation;Evaluation of Traditional Chinese Medicine Syndrome Efficacy; | — |
Countries
China
Contacts
Public ContactZhai Xiaofeng
The First Affiliated Hospital of Naval Medical University
Outcome results
None listed